The global fiducial markers market is foreseen to grow at 4.1%, from USD 112.3 Million in 2021 to
USD 154.9 Million in 2029. Rise in adoption of fiducial markers in radiology,
and technological advancements in the field of Fiducial Markers.
Adoption of cutting-edge
technologies in hospitals and medical sectors has boosted the growth of manufacturers
of fiducial markers.
COVID-19 Impact on Global Fiducial Markers
Market
The fiducial markers is the supply line for organ transplantation, helping treat patients.
The continuous spread of COVID-19 has caused a massive decrease in organ
donation, thus negatively impacting the aspects of Fiducial Markers in recent
years. However, government and private entities have various strategies to
deliver proper care to patients during organ transplantation.
Market Segmentation
For the purpose
of this report, the global Fiducial Markers market is segmented on the basis of
product type, modality type, cancer type, end user and region:
Product Type Outlook (Revenue, USD million;
2018-2029)
|
Metal-based Markers
|
Metal-based Markers
|
|
Pure Gold
|
|
Gold Alloys
|
|
Other Metal-based Markers
|
Polymer-based Markers
|
Other Fiducial Markers
|
|
|
|
Modality Type Outlook (Revenue, USD
million; 2018-2029)
|
CT/CBCT
|
|
|
MRI
|
|
|
Ultrasound
|
|
|
Radiotherapy
|
|
|
|
|
|
Cancer Type Outlook (Revenue, USD million;
2018-2029)
|
Prostate Cancer
|
|
|
Lung Cancer
|
|
|
Breast Cancer
|
|
|
Gastric Cancer
|
|
|
Other Cancers
|
|
|
|
|
|
End User Outlook (Revenue, USD million;
2018-2029)
|
Hospitals & Outpatient Facilities
|
|
Independent Radiotherapy Centers
|
|
Cancer Research Centers
|
|
Product Type Outlook:
On the basis of
product type, the market is segmented into metal-based markers, polymer-based
markers, other fiducial markers.
Figure 1 - Fiducial Markers Market, By Product
Type (Market Size And Forecast By Value - USD Million, 2021 & 2029)

Modality Outlook:
On the basis of
modality, the market is segmented into CT/CBCT, MRI, ultrasound, radiotherapy.
Figure 2 - Modality Outlook (Revenue, USD
Million, 2021)
